Ceva Santé Animale preps refi and dividend loan

Ceva Santé Animale, a French company which develops vaccines and pharmaceuticals for animals, is preparing to raise a €2.15bn loan package to refinance and to pay a dividend.

  • By Owen Sanderson
  • 07 Mar 2019
The new deal will include a €2bn seven year term loan B, a 6.5 year €100m revolver, and a

Please take a trial or subscribe to access this content.

Contact our subscriptions team to discuss your access: subs@globalcapital.com

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.

Bookrunners of European Leveraged Loans

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 Deutsche Bank 1,517.16 8 7.69%
2 Goldman Sachs 1,495.21 6 7.58%
3 Credit Agricole CIB 1,179.51 9 5.98%
4 BNP Paribas 1,084.57 11 5.50%
5 Bank of America Merrill Lynch 1,011.25 5 5.13%

Bookrunners of European HY Bonds

Rank Lead Manager Amount €m No of issues Share %
  • Last updated
  • Today
1 Citi 849.80 7 9.30%
2 JPMorgan 703.06 6 7.69%
3 Deutsche Bank 636.38 4 6.97%
4 BNP Paribas 604.64 5 6.62%
5 Goldman Sachs 489.41 4 5.36%

Bookrunners of Dollar Denominated HY Bonds

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 Citi 7,643.05 50 10.93%
2 JPMorgan 6,601.02 49 9.44%
3 Bank of America Merrill Lynch 5,031.63 36 7.19%
4 Goldman Sachs 4,767.07 33 6.81%
5 Credit Suisse 4,456.07 30 6.37%